PPE was reported in 16% of multiple myeloma patients treated with Caelyx plus bortezomib combination therapy.
PPE- d täheldati 16% multiipelmüeloomi põdevatest patsientidest, kes said Caelyx’ i ja bortesomiibi kombinatsioonravi.